IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,095,156 | $46,105,783 | $34,114,839 | $56,100,792 |
| - Cash | $288,266 | $453,932 | $112,546 | $144,454 |
| + Debt | $986,948 | $1,067,353 | $1,470,033 | $1,031,009 |
| Enterprise Value | $34,793,838 | $46,719,204 | $35,472,326 | $56,987,347 |
| Revenue | $3,897,504 | $3,660,953 | $3,367,324 | $3,215,360 |
| % Growth | 6.5% | 8.7% | 4.7% | – |
| Gross Profit | $2,378,927 | $2,189,970 | $2,004,338 | $1,889,432 |
| % Margin | 61% | 59.8% | 59.5% | 58.8% |
| EBITDA | $1,275,840 | $1,217,665 | $1,014,530 | $1,039,858 |
| % Margin | 32.7% | 33.3% | 30.1% | 32.3% |
| Net Income | $887,867 | $845,042 | $679,089 | $744,845 |
| % Margin | 22.8% | 23.1% | 20.2% | 23.2% |
| EPS Diluted | 10.67 | 10.06 | 8.03 | 8.6 |
| % Growth | 6.1% | 25.3% | -6.6% | – |
| Operating Cash Flow | $929,001 | $906,510 | $542,984 | $755,546 |
| Capital Expenditures | -$130,922 | -$133,631 | -$148,838 | -$119,549 |
| Free Cash Flow | $798,079 | $772,879 | $394,146 | $635,997 |